-
Spin-off of Novartis’ Alcon Business and Listing of Alcon Shares on the SIX and the NYSE
Alcon Inc., the largest eye care device company in the world, with complementary businesses in surgical and vision care, announced its debut as an independent, publicly traded company and the completion of its separation from Novartis on 9 April 2019, the day the company’s shares began trading on the SIX Swiss Exchange and New York…
Reference: CapLaw-2019-21